ENTX
ENTX
NASDAQ · Biotechnology

Entera Bio Ltd

$1.04
-0.13 (-11.11%)
As of Feb 8, 2:18 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 9.29M 9.20M 8.70M
Net Income -2,793,034 -2,830,498 -1,987,756
EPS
Profit Margin -30.1% -30.8% -22.8%
Rev Growth +3.0% +9.2% +11.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 8.48M 7.94M 8.67M
Total Equity 26.97M 25.38M 23.96M
D/E Ratio 0.31 0.31 0.36
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -2,857,375 -2,581,372 -2,786,589
Free Cash Flow -3,645,818 -3,568,526 -2,022,520